Hunan Province Tumor Hospital

This study is testing whether the time of day a patient receives immunotherapy affects how well it shrinks their tumor before surgery. Patients with stage II-III non-small cell lung cancer will receive standard pre-surgery treatment and be randomly assigned to get their immunothe…